Combination Chemotherapy with Selected Polyphenols in Preclinical and Clinical Studies—An Update Overview
Molecules · 26.04.2023 · 28 (9) · 3746
DOI: 10.3390/molecules28093746 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Molecules, online erschienen am 26.04.2023. Verfasst von Cvijeta Jakobušić Brala und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10 000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Polyphenols, Curcumin. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Academic and Research Libraries Consortium (CARLC).
Themen: Onkologische Pflege
Abstract (Originalsprache)
This review article describes studies published over the past five years on the combination of polyphenols, which are the most studied in the field of anticancer effects (curcumin, quercetin, resveratrol, epigallocatechin gallate, and apigenin) and chemotherapeutics such as cisplatin, 5-fluorouracil, oxaliplatin, paclitaxel, etc. According to WHO data, research has been limited to five cancers with the highest morbidity rate (lung, colorectal, liver, gastric, and breast cancer). A systematic review of articles published in the past five years (from January 2018 to January 2023) was carried out with the help of all Web of Science databases and the available base of clinical studies. Based on the preclinical studies presented in this review, polyphenols can enhance drug efficacy and reduce chemoresistance through different molecular mechanisms. Considering the large number of studies, curcumin could be a molecule in future chemotherapy cocktails. One of the main problems in clinical research is related to the limited bioavailability of most polyphenols. The design of a new co-delivery system for drugs and polyphenols is essential for future clinical research. Some polyphenols work in synergy with chemotherapeutic drugs, but some polyphenols can act antagonistically, so caution is always required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10 000 Zagreb, Croatia.
ORCID-Profile: Cvijeta Jakobušić Brala, Monika Barbarić
Förderung
- Croatian Academic and Research Libraries Consortium (CARLC)
Zitieren
APA
Jakobušić Brala, C., Karković Marković, A., Kugić, A., Torić, J., & Barbarić, M. (2023). Combination Chemotherapy with Selected Polyphenols in Preclinical and Clinical Studies—An Update Overview. Molecules, 28(9), 3746. https://doi.org/10.3390/molecules28093746
Vancouver
Jakobušić Brala C, Karković Marković A, Kugić A, Torić J, Barbarić M. Combination Chemotherapy with Selected Polyphenols in Preclinical and Clinical Studies—An Update Overview. Molecules. 2023;28(9):3746. doi:10.3390/molecules28093746
BibTeX
@article{JakobuiBrala2023,
author = {Jakobušić Brala, Cvijeta and Karković Marković, Ana and Kugić, Azra and Torić, Jelena and Barbarić, Monika},
title = {Combination Chemotherapy with Selected Polyphenols in Preclinical and Clinical Studies—An Update Overview},
journal = {Molecules},
year = {2023},
volume = {28},
number = {9},
pages = {3746},
doi = {10.3390/molecules28093746}
}
EUVIMED